Retatrutide Dosage Calculator
LY3437943 (investigational)
Retatrutide (the triple GLP-1/GIP/glucagon agonist, code-named LY3437943) is still investigational. There's no FDA label yet, so the numbers below come from Eli Lilly's phase 2 trials rather than a pharmacy insert. In the obesity trial, people started at 2 mg once weekly and stepped up every 4 weeks or so toward a 4, 8, or 12 mg maintenance dose. The 12 mg group lost about 24% of their body weight by week 48. Enter your vial size and target dose and the calculator tells you exactly what to draw.
Common Retatrutide doses (once weekly)
Concentration
5.00
mg/ml
5000 mcg/ml
Volume per Dose
0.400
ml
Draw this amount
Syringe Draw
40
IU
100-unit insulin syringe
Supply per Vial
5.0
weeks
At 2 mg/week
Draw to
40.0 units
Draw to this line
Where to buy Retatrutide
COA-verified research vials at BHG Labs. Use code REDDIT for 10% off. Affiliate link — research use only.
Retatrutide Titration Schedule & Dose Chart
Syringe units below assume a 10 mg vial in 2 ml of BAC water (5.0 mg/ml). Adjust the calculator above for your own mix.
| Week | Weekly Dose | Volume | Syringe Draw |
|---|---|---|---|
| 1-4 | 2 mg | 0.40 ml | 40 IU |
| 5-8 | 4 mg | 0.80 ml | 80 IU |
| 9-12 | 8 mg | 1.60 ml | 160 IU |
| 13+ | 12 mg | 2.40 ml | 240 IU |
Maximum studied dose: 12 mg once weekly. Step up only if side effects are tolerable.
Retatrutide is investigational and not FDA-approved. These figures come from published clinical-trial data, not a pharmacy label, and are for research and educational purposes only. This is not medical advice.
Retatrutide Dosing FAQ
Research basis
Free 2026 Peptide Cheat Sheet — 50 pages, PDF
Dosing, reconstitution, stacks, half-lives, and vendor trust tiers. The reference we wish we had on day one.
